相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reduced hospitalization for heart failure using anti-diabetic drug dapagliflozin: implications of DECLARE-TIMI 58 for the basic science community
Hidekazu Kondo et al.
CARDIOVASCULAR RESEARCH (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial
Milton Packer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction The DEFINE-HF Trial
Michael E. Nassif et al.
CIRCULATION (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effects of Serelaxin in Patients with Acute Heart Failure
Marco Metra et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA- REG OUTCOME Trial
David Fitchett et al.
CIRCULATION (2019)
Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrumof heart failure risk in the EMPA-REG OUTCOME® trial
David Fitchett et al.
EUROPEAN HEART JOURNAL (2018)
Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program
Karin Radholm et al.
CIRCULATION (2018)
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
Subodh Verma et al.
DIABETOLOGIA (2018)
Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure
Jorge Rubio-Gracia et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
SGLT2 inhibitors: practical considerations and recommendations for cardiologists
Erika Opingari et al.
CURRENT OPINION IN CARDIOLOGY (2018)
Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure
M. Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial
David Fitchett et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Terminology and definition of changes renal function in heart failure
Kevin Damman et al.
EUROPEAN HEART JOURNAL (2014)
Diuretic response in acute heart failure: clinical characteristics and prognostic significance
Mattia A. E. Valente et al.
EUROPEAN HEART JOURNAL (2014)
The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the Modification of Diet in Renal Disease equation for estimating glomerular filtration rate in chronic systolic heart failure
Mattia A. E. Valente et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes
H. J. Lambers Heerspink et al.
DIABETES OBESITY & METABOLISM (2013)
Timing of Hemoconcentration During Treatment of Acute Decompensated Heart Failure and Subsequent Survival Importance of Sustained Decongestion
Jeffrey M. Testani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Diuretic Strategies in Patients with Acute Decompensated Heart Failure
G. Michael Felker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rolofylline, an Adenosine A(sub 1)-Receptor Antagonist, in Acute Heart Failure.
Barry M. Massie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
分享论文
